This Is the No. 1 Risk Factor for Dementia That You Can Actually Prevent, According to a Geriatrician - TODAY.com
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
As we get older, the world gradually starts looking and sounding a little different. Our vision may not be as sharp as it once was, and we may need to hit the “increase volume” button on the remote a few extra times to hear the television. Most people will experience some degree of age-related hearing loss, which usually becomes more apparent over the age of 60, Dr. Stephanie Rogers, a professor of medicine in the division of geriatrics at the University of California San Francisco School of Medicine, tells TODAY.com. However, hearing problems can begin even earlier in life. And leaving them unaddressed may seriously impact the brain, increasing the risk of cognitive decline, says Rogers. Longevity Tip of the Day: Address Hearing Loss to Lower Your Risk of Developing DementiaUntreated hearing loss is the No. 1 modifiable risk factor for dementia, says Rogers. Modifiable risk factors are behaviors or exposures that can influence our risk of developing a disease. Unlike non-modifiable risk factors, such as our genetics, these can be changed. Hearing loss typically begins subtly in early adulthood and slowly accrues over decades.
This article is an excerpt. To read the full content, visit the original source. TODAY.com
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!